Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York (I.B.K., E.L., T.P.S.); Tri-Institutional PhD Program in Chemical Biology, New York, New York (I.B.K.); Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Solna, Sweden (J.M.S.); Department of Pharmacology and Toxicology, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin, New Zealand (D.L.H.); and Department of Neurobiology, Care Sciences and Society (NVS), Division for Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden (T.P.S.).
Laboratory of Chemical Biology and Signal Transduction, The Rockefeller University, New York, New York (I.B.K., E.L., T.P.S.); Tri-Institutional PhD Program in Chemical Biology, New York, New York (I.B.K.); Science for Life Laboratory, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, Solna, Sweden (J.M.S.); Department of Pharmacology and Toxicology, School of Biomedical Sciences, Division of Health Sciences, University of Otago, Dunedin, New Zealand (D.L.H.); and Department of Neurobiology, Care Sciences and Society (NVS), Division for Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Solna, Sweden (T.P.S.)
Pharmacol Rev. 2023 Jan;75(1):1-34. doi: 10.1124/pharmrev.120.000180. Epub 2022 Dec 8.
G protein-coupled receptors (GPCRs) are known to interact with several other classes of integral membrane proteins that modulate their biology and pharmacology. However, the extent of these interactions and the mechanisms of their effects are not well understood. For example, one class of GPCR-interacting proteins, receptor activity-modifying proteins (RAMPs), comprise three related and ubiquitously expressed single-transmembrane span proteins. The RAMP family was discovered more than two decades ago, and since then GPCR-RAMP interactions and their functional consequences on receptor trafficking and ligand selectivity have been documented for several secretin (class B) GPCRs, most notably the calcitonin receptor-like receptor. Recent bioinformatics and multiplexed experimental studies suggest that GPCR-RAMP interactions might be much more widespread than previously anticipated. Recently, cryo-electron microscopy has provided high-resolution structures of GPCR-RAMP-ligand complexes, and drugs have been developed that target GPCR-RAMP complexes. In this review, we provide a summary of recent advances in techniques that allow the discovery of GPCR-RAMP interactions and their functional consequences and highlight prospects for future advances. We also provide an up-to-date list of reported GPCR-RAMP interactions based on a review of the current literature. SIGNIFICANCE STATEMENT: Receptor activity-modifying proteins (RAMPs) have emerged as modulators of many aspects of G protein-coupled receptor (GPCR)biology and pharmacology. The application of new methodologies to study membrane protein-protein interactions suggests that RAMPs interact with many more GPCRs than had been previously known. These findings, especially when combined with structural studies of membrane protein complexes, have significant implications for advancing GPCR-targeted drug discovery and the understanding of GPCR pharmacology, biology, and regulation.
G 蛋白偶联受体 (GPCR) 已知与其他几类调节其生物学和药理学的整合膜蛋白相互作用。然而,这些相互作用的程度及其作用机制尚不清楚。例如,一类与 GPCR 相互作用的蛋白质,即受体活性修饰蛋白 (RAMP),由三种相关的、普遍表达的单跨膜跨度蛋白组成。RAMP 家族是在二十多年前发现的,从那时起,GPCR-RAMP 相互作用及其对受体运输和配体选择性的功能后果已在几种分泌素 (B 类) GPCR 中得到记录,最著名的是降钙素受体样受体。最近的生物信息学和多路复用实验研究表明,GPCR-RAMP 相互作用可能比以前预期的更为广泛。最近,低温电子显微镜提供了 GPCR-RAMP-配体复合物的高分辨率结构,并且已经开发出针对 GPCR-RAMP 复合物的药物。在这篇综述中,我们总结了允许发现 GPCR-RAMP 相互作用及其功能后果的最新技术进展,并强调了未来进展的前景。我们还根据对当前文献的回顾,提供了一份报告的 GPCR-RAMP 相互作用的最新列表。
受体活性修饰蛋白 (RAMP) 已成为 G 蛋白偶联受体 (GPCR) 生物学和药理学许多方面的调节剂。应用新技术研究膜蛋白-蛋白相互作用表明,RAMP 与比以前已知的更多的 GPCR 相互作用。这些发现,尤其是与膜蛋白复合物的结构研究相结合,对推进 GPCR 靶向药物发现以及对 GPCR 药理学、生物学和调节的理解具有重要意义。